Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report. - Murakami S; Yamagishi K; Kitani A; Ueta T; Matsuura Y; Kubota T; Uezono Y (Journal of palliative medicine, 2026)